
News|Articles|June 18, 2024
The Nuances of Patient Selection: Why Some Trials Need Eligibility Adjudication
Author(s)WCG
Patient selection can be a nuanced process in clinical trials, particularly those involving therapeutic areas with more complex or subjective inclusion/exclusion criteria. Determining patient eligibility may often depend on factors that require clinical expertise in such areas as disease progression, comorbidities, genetic mutations, and disease severity. Discover the role eligibility adjudication committees play in ensuring trial success.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Trending on Applied Clinical Trials Online
1
Getting Clinical Outsourcing Right
2
Modernizing Recruitment with Data, HCP Networks, and Last Mile Support
3
ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes
4
Decision Inputs in Drug Development—Big Vs. Small Pharma: Is There a Difference?
5

.png)



.png)



.png)
.png)
